Back to funds

Versant Venture Management, LLC

hedge fundUpdated 9 days ago

Managed by Versant Venture Management, Llc • Latest filing Q3 2026

Portfolio value
$109.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$151.1M
Q1 2026$141.4M
Q2 2026$162.6M
Q3 2026$109.1M

Top holdings

8 positions as of Q3 2026

View filing
M

Monte Rosa Therapeutics, Inc.

Value
$37.9M
Shares
3.18M
% Port
34.78%
C

Century Therapeutics, Inc.

Value
$20.8M
Shares
12.17M
% Port
19.07%
C

Contineum Therapeutics, Inc.

Value
$17.3M
Shares
1.29M
% Port
15.90%
J

Jade Biosciences, Inc.

Value
$13.9M
Shares
991.8K
% Port
12.77%
L

Lenz Therapeutics, Inc.

Value
$10.2M
Shares
2.66M
% Port
9.35%
C

CRISPR Therapeutics AG

Value
$8.2M
Shares
148.8K
% Port
7.55%
S

Skye Bioscience, Inc.

Value
$404K
Shares
251.0K
% Port
0.37%
T

Tempest Therapeutics, Inc.

Value
$225K
Shares
269.8K
% Port
0.21%

Explore